Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation

Infection and Immunity

Volumn 74, Issue 1, 2006, Pages 213-224

  Jeevan, A ^a   McFarland, C T ^a   Yoshimura, T ^b   Skwor, T ^a,c   Cho, H ^a   Lasco, T ^a,d   McMurray, D N ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d Mycos Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; COMPLEMENTARY DNA; HISTIDINE; HYDROGEN PEROXIDE; MESSENGER RNA; NITRIC OXIDE; RECOMBINANT GAMMA INTERFERON;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCG VACCINATION; CELL GROWTH; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; FIBROBLAST; GUINEA PIG; IMMUNE RESPONSE; INTERFERON PRODUCTION; LUNG TUBERCULOSIS; MACROPHAGE ACTIVATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; ANTITUBERCULAR AGENTS; ANTIVIRAL AGENTS; CELL LINE; GUINEA PIGS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; HYDROGEN PEROXIDE; INTERFERON-GAMMA, RECOMBINANT; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; NITRITES; RABBITS; TUBERCULOSIS, PULMONARY;

EID: 29644444315     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.1.213-224.2006     Document Type: Article

References (52)

1. Barnes, P. F., S. J. Fong, P. J. Brennan, P. E. Twomey, A. Mazumder, and R. L. Modlin. 1990. Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis. J. Immunol. 145:149-154.
2. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
3. Cho, H., T. M. Lasco, S. Sedberry, T. Yoshimura, and D. N. McMurray. 2005. Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages. Infect. Immun. 73:1367-1376.
4. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698-702.
5. Cooper, A. M. D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247.
6. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742.
7. Denis, M. 1994. Monocytes/macrophages: NO or no NO? J. Leukoc. Biol. 55:682-684.
8. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
9. Dorman, S. E., and S. M. Holland. 1998. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J. Clin. Investig. 101:2364-2369.
10. Drapier, J. C., and J. B. Hibbs, Jr. 1988. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol. 140:2829-2838.
11. Flesch, I. E., and S. H. Kaufmann. 1990. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 58:2675-2677.
12. Flesch, I. E. A., and S. H. E. Kaufmann. 1991. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59:3213-3218.
13. Flesch, I. E., J. H. Hess, I. P. Oswald, and S. H. Kaufmann. 1994. Growth inhibition of Mycobacterium bovis by IFN-γ stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10. Int. Immunol. 6:693-700.
14. Flynn, J. L., M. M. Goldstein, K. J. Triebold, D. K. Dalton, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013-12017.
15. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
16. Fulton, S. A., S. M. Reba, R. K. Pai, M. Pennini, M. Torres, C. L. Harding, and W. H. Boom. 2004, Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Infect. Immun. 72:2101-2110.
17. Gazzinelli, R. T., I. P. Oswald, S. L. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ activated macrophages. J. Immunol. 148:1792-1796.
18. Holscher, C., R. A. Atkinson, B. Arendse, N. Brown, E. Myburgh, G. Alber, and F. Brombacher. 2001. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167:6957-6966.
19. Jeevan, A., C. D. Bucana, Z. Dong, V. Dizon, S. L. Thomas, T. E. Lloyd, and M. L. Kripke. 1995. Ultraviolet radiation reduces phagocytosis and intracellular killing of mycobacteria and inhibits nitric oxide production by macrophages in mice. J. Leukoc. Biol. 57:883-890.
20. Jeevan, A., T. Yoshimura, G. Foster, and D. N. McMurray. 2002. Effect of BCG infection on interleukin-1β and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria. Infect. Immun. 70:1245-1253.
21. Jeevan, A., T. Yoshimura, K. E. Lee, and D. N. McMurray. 2003. Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination. Infect. Immun. 71:354-364.
22. Kaufmann, S. H. E. 1987. Towards new leprosy and tuberculosis vaccines. Microbiol. Sci. 4:324-328.
23. Kemijo, R., J. Le, D. Shapiro, E. A. Havell, S. Huang, M. Aguet, M. Bosland, and J. Vilcek. 1993. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178:1435-1440.
24. Kemijo, R., D. Shapiro, J. Le, S. Huang, M. Aguet, and J. Wilcek. 1993. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc. Natl. Acad. Sci. USA 90:6626-6630.
25. Kemijo, R., J. Gerecitano, D. Shapiro, S. J. Green, M. Aguet, J. Le, and J. Vilcek. 1995. Generation of nitric oxide and clearance of interferon-gamma after BCG infection are impaired in mice that lack the interferon-gamma receptor. J. Inflamm. 46:23-31.
26. Kerr, I. M., and G. R. Stark. 1992. The antiviral effects of the interferons and their inhibition. J. Interferon Res. 12:237-240.
27. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740.
28. Lasco, T. M., T. Yamamoto, T. Yoshimura, S. S. Allen, L. Cassone, and D. N. McMurray. 2003. Effect of Mycobacterium bovis BCG vaccination on mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations. Infect. Immun. 71:7035-7042.
29. Lasco, T. M., L. Cassone, H. Kamohara, T. Yoshimura, and D. N. McMurray. 2005. Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig. Tuberculosis 85:245-258.
30. Levasseur, P. R., D. Lecointe, G. Bertrand, and M. Fay. 1996. Differential nitric oxide (NO) production by macrophages from mice and guinea pigs infected with virulent and avirulent Legionella pneumophila serogroup 1. Clin. Exp. Immunol. 104:48-53.
31. Lyons, M. J., T. Yoshimura, and D. N. McMurray. 2002. Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis. Infect. Immun. 70:5471-5478.
32. Lyons, M. J., T. Yoshimura, and D. N. McMurray. 2004. Interleukin (IL)-8 (CXCL8) induces cytokine expression and superoxide formation by guinea pig neutrophils infected with Mycobacterium tuberculosis. Tuberculosis 84:283-292.
33. Mackaness, G. B. 1969. The immunology of antituberculous immunity. Am. Rev. Respir. Dis. 97:337-344.
34. Michel, O., A. Hess, J. Su, W. Bloch, E. Stennert, and K. Addicks. 2000. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the hydropic cochlea of guinea pigs. Hearing Res. 143:23-28.
35. Miller, M. J., J. H. Thompson, X. J. Zhang, H. Sadowska-Krowicka, J. L. Kakkis, U. K. Munshi, M. Sandoval, J. L. Rossi, S. Eloby-Childress, J. S. Beckman, et al. 1995. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology 109:1475-1483.
36. Muijsers, R. B. R., N. H. T. ten Hacken, I. V. Ark, G. Folkerts, F. P. Nijkamp, and D. S. Postma. 2001. L-Arginine is not the limiting factor for nitric oxide synthesis by human alveolar macrophages in vitro. Eur. Respir. J. 18:667-671.
37. Nathan, C. F., H. W. Murray, M. E. Wiebe, and B. Y. Rubin. 1983. Identification of interferon gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:670-689.
38. Noss, E. H., R. K. Pai, T. J. Sellati, J. D. Radolf, J. Belisle, D. T. Golenbock, W. H. Boom, and C. V. Harding. 2001. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167:910-918.
39. Orme, I. M., E. S. Miller, A. D. Roberts, S. K. Furney, J. P. Griffin, K. M. Dobos, D. Chi, B. Rivoire, and P. J. Brennan. 1992. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J. Immunol. 148:189-196.
40. Pick, E. 1986. Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods Enzymol. 132:407-421.
41. Pierre-Audigier, C., E. Jouanguy, S. Lamhamedi, F. Altare, J. Rauzier, V. Vincent, D. Canioni, J. F. Emile, A. Fischer, S. Blanche, J. L. Gaillard, and J. L. Casanova. 1997. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin. Infect. Dis. 24:982-984.
42. Prado, C. M., E. A. Leick-Maldonado, V. Arata, D. I. Kasahara, M. A. Martins, and I. F. L. C. Tiberio. 2004. Neurokinins and inflammatory cell iNOS expression in guinea pigs with chronic allergic airway inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L741-L748.
43. Roederer, M., A. Treister, W. Moore, and L. A. Herzenberg. 2001. Probability binning comparison: a metric for quantitating univariate distribution differences. Cytometry 45:37-46.
44. Sharp, A., K. Sharp, and D. K. Banerjee. 1986. Effect of interferon on hydrogen peroxide production by cultured mouse peritoneal macrophages. Infect. Immun. 54:597-599.
45. Steeg, P. A., R. N. Moore, H. M. Johnson, M. Muramatsu, S. Kobayashi, and T, Sudo. 1982. Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J. Exp. Med. 156:1780-1793.
46. Verreck, F. A., T. de Boer, D. M. Langernberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. Ottenhoff. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101:4560-4565.
47. Wadee, A. A., R. H. Kuschke, and T. G. Dooms. 1995. The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants. Clin. Exp. Immunol. 100:434-439.
48. Weinberg, J. B. 1998. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol. Med. 4:557-591.
49. Wheelock, E. F. 1965. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 149:310-311.
50. Yam, L. T., C. Y. Li, and W. H. Crosby. 1971. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol. 55:283-290.
51. Yamamoto, T., A. Jeevan, K. Ohishi, Y. Nojima, K. Umemori, S. Yamamoto, and D. N. McMurray. 2002. A new system for guinea pig interferon biological activity. J. Interferon Cytokine Res. 22:793-797.
52. Zhang, X., and D. N. McMurray. 1998. Suppression of lymphoproliferation by alveolar macrophages in the guinea pig. Tuber. Lung Dis. 79:119-126.